Study type

Study topic

Human medicinal product

Study type

Non-interventional study

Scope of the study

Effectiveness study (incl. comparative)

Data collection methods

Primary data collection
Non-interventional study

Non-interventional study design

Other

Non-interventional study design, other

Survey of physician knowledge
Study drug and medical condition

Name of medicine

CAPRELSA

Medical condition to be studied

Medullary thyroid cancer
Population studied

Short description of the study population

Physicians who were targeted to receive the Caprelsa educational pack at the time of launch.

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)

Estimated number of subjects

1
Study design details

Main study objective

The study objective is to assess the knowledge and understanding of physicians in relation to the key elements in the Caprelsa educational material.

Outcomes

The primary outcome is the level of understanding of the benefit:risk profile of Caprelsa prescribers/potential prescribers as demonstrated by the results of the prescriber survey.

Data analysis plan

The responses to each survey question will be reported as descriptive statistics. The frequency distribution of responses to each question (the number and percentage of respondents who give answers to each response option) will be presented. Each question will be evaluated individually. The following will be reported, as appropriate, as part of this analysis:• The number of invitations issued to healthcare providers• The number and percentage of healthcare providers eligible for participation• The number and percentage of healthcare providers who completed the survey• Frequency distribution of responses to each survey question (the number of and percentage of respondents who give each answer to each question)Additional analyses may be performed as needed.
Documents
Study results

Vandetanib Physican Survey Study Report - 22JUN2018

English (469.24 KB - PDF)View document